Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research PharmiWeb, 14 Feb 2020 Paper demonstrates ensifentrine’s potential in improving lung function and quality of life symptoms LONDON, February 14, 2020 …